The State-of-the-art in Improving the Antitumor Efficacy of Platinum Drugs
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 764
Special Issue Editors
Interests: bioinorganic chemistry; bioorganometallic chemistry; medicinal inorganic chemistry; biologically active transition metal complexes; metal-based (in particular, platinum) anticancer agents; drug targeting and delivery; inorganic electrochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: bioinorganic chemistry; coordination compounds; Pt complexes as potential antitumor drugs; drug targeting and delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the development of personalized medicine within oncology, traditional platinum-based drugs are still difficult to replace, even considering their weaknesses. However, we can try to improve them with more suitable pharmacological properties. This goal can only be achieved with an approach that is multi-, inter-, and trans-disciplinary at the same time.
The aim of this Special Issue is precisely to stimulate a dialogue between different disciplines to collect new ideas and suggestions from diverse areas of science, independently from the classification of new drugs. In this spirit ‘Pharmaceutics’ and ‘Molecules’ reached a unanimous decision to create a joint Special Issue titled “The State-of-the-art in Improving the Antitumor Efficacy of Platinum Drugs”. The unifying goal of the Special Issue is contained within these words: to share ideas, positive experiences, and (why not?) failures showing the ability of platinum-based anticancer agents to kill cancer cells with biological mechanisms that are different from those used by the reference drug cisplatin, to bypass chemoresistance, to be activated preferentially at the tumor site only, to be delivered more selectively to the final target, and to have a final target that is not only DNA. These are just some suggestions, but they are not binding. For example, one possible way of improving the antitumor efficacy of platinum drugs is… not to use platinum! For this reason, candidate drugs containing metals aside from platinum are also welcome. Original or review articles concerning the above-said topics and studies on computer-aided drug design, in silico studies, drug repurposing, pharmacokinetics, and pharmacodynamics are greatly encouraged.
We look forward to receiving your contributions.
You may choose our Joint Special Issue in Molecules.
Prof. Dr. Mauro Ravera
Dr. Elisabetta Gabano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinorganic chemistry
- metal-based drugs
- pt coordination compounds
- pharmacodynamics
- pharmacokinetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
